Phase 2 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 60 years of age
- People who can understand spoken English well enough to follow the testing procedures
- People who scored below a certain threshold on a social network questionnaire used during screening (the trial site can explain this score in more detail)
- People who have received a formal diagnosis of schizophrenia according to current diagnostic guidelines (DSM-5)
- People whose condition has been clinically stable — meaning no hospital stays in the past 6 months, no medication changes in the past 6 months, and no more than moderate positive symptoms currently
Who may not be able to join:
- People with a medical history indicating an IQ below 70 or a developmental disability
- People currently taking opioid medications
- People with a medically significant neurological condition (such as epilepsy), heart condition (such as irregular heartbeat), or breathing condition (such as asthma), based on medical history
- People with a history of serious head injury — for example, loss of consciousness for more than an hour, lasting cognitive effects, or rehabilitation treatment following a head injury
- People with a substance or alcohol use disorder in the past six months, or any history of opioid use disorder
- People who have taken sedatives or benzodiazepines within 24 hours before testing
- People who test positive on a urine drug screen or show visible signs of intoxication on the day of assessment
- People who are pregnant or think they may be pregnant, based on self-report and urine testing
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 3107945577
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Attention bias
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.